Remember, tomorrow is the nephrology conference where AEMD CEO will present data regarding treatment of HCV (the company's primary focus to begin commercialization) with their Hemopurifier:
Aethlon Medical Announces Presentation of Hepatitis-C (HCV) Clinical Data at 42nd Annual American Society of Nephrology (ASN) Conference
Thursday 10/15/2009 8:00 AM ET - Pr Newswire
As of 2:44 PM ET 10/29/09
Aethlon Medical, Inc. (OTC Bulletin Board: AEMD) disclosed today that clinical data resulting from the treatment of Hepatitis-C (HCV) infected patients with the Aethlon Hemopurifier(R) will be presented at the 42nd Annual Meeting & Scientific Exposition of the American Society of Nephrology (ASN). Dr. Vijay Kher, principal investigator of the Hemopurifier(R) studies and Director of Nephrology at the Fortis Hospital in New Delhi, India will present and discuss Hemopurifier(R) treatment results from 10am-12pm pacific time on October 30th, 2009. The event is being held at The San Diego Convention Center in San Diego, California.
